Bristol Myers
West Virginia is taking part in a multi-million-dollar settlement with Bristol-Myers Squibb. The deal centers on the marketing of a drug used to manage mental health disorders and includes 43 states in the settlement. The drug maker had been accused of misrepresenting the risks and results of the drug’s dementia treatment. West Virginia’s share of the settlement will exceed a quarter-of-a-million-dollars.